Frontiers of care

It’s not just about tests that need to be reported on, but an ever-increasing focus on the patient. Thanks to AI, the specialist remains at the heart of the diagnosis and treatment process.

Radiologists: how artificial intelligence frees up time for building relationships with patients

The therapy offers a treatment option regardless of the specific genetic mutation, thereby increasing the number of patients who can benefit from it

Duchenne muscular dystrophy: Prix Galien awarded to Italian drug that slows the progression of the disease

Early diagnosis and management are crucial for those living with dysphagia: new treatment prospects from research

Eosinophilic oesophagitis: what the symptoms are, why it is important to recognise it, and what to do

From 21 to 23 October, works by Andrea Olivari and Lucamaleonte will be on display at Palazzo Merulana in Rome to mark the 80th anniversary of Bristol Myers Squibb’s presence in Italy

In Rome, sculptures and live painting to build a bridge between art and science  

The questions relate to diagnosis and treatment options, but also to sexuality, continence, relationships and the possibility of maintaining one’s usual habits

Prostate cancer: a list of questions for 485,000 patients

Italfarmaco will market JR-141 exclusively in the United States, Europe and Latin America, subject to regulatory approval

Italfarmaco and JCR Pharmaceuticals: agreement on a new experimental treatment

It is not a rare condition, but far too little is still known about it: it is vital to raise awareness in order to achieve early diagnosis

Hypertrophic cardiomyopathy: new treatments when it is discovered that the heart is thickening

‘Smart’ drugs improve outcomes compared with standard care, but the treatment is recommended only in specific cases and for certain mutations

Lung cancer: monoclonal antibody conjugate reduces the risk of disease progression

AIFA has given the go-ahead for acalabrutinib in combination with venetoclax. The drug has also been given the green light, in combination with chemo-immunotherapy, for the rarer mantle cell lymphoma

Chronic lymphocytic leukaemia: a new targeted ‘combination’ for first-line treatment

The Network connects 160 clinical centres and 60 laboratories on a digital platform to promote equal access to advanced, certified molecular diagnostics and could provide access to innovative research projects

Labnet, in 20 years 200,000 examinations and 6.8 million benefit for the SSN

The appeal of clinicians and associations: only half of the patients manage to access the test for ESR1 mutations

Metastatic breast cancer: release 15 million for liquid biopsy

Aifa green light for a drug indicated alone in advanced stages for oesophagus and lung and together with chemo for gastric and oesophageal malignancies

Tumours, immunotherapy advances: cures for oesophagus and stomach, plus lung

Conference at the ministry, flash mob and exhibition in Piazza del Popolo in Rome: the associations present an agenda with six goals to be achieved

Ovarian cancer: by 2030 reference centres for 90% of patients

Aifa approves reimbursability of darolutamide with androgen deprivation therapy: improves disease control and quality of life for patients

Prostate cancer: with innovative drugs, treatment becomes personalised

Subcutaneous administration of nivolumab within minutes offers important advantages for patients with different malignancies with the same clinical efficacy

Tumours: immunotherapy is increasingly less burdensome for the patient and the hospital

In the summer, young Italian doctors will join their Albanian colleagues in screening and awareness-raising activities and to strengthen the roots of a broad collaboration that will include research and training

One Health Foundation: project in 36 summer centres in Albania and on the 'health ship' 550 tests and visits

Free medical examinations and check-ups will be carried out at ten clinics by 17 specialists from different disciplines

Italia-Albania: prevention goes on board the Health Ship

For the president of Imi, Daniela Massi, constant dermatological check-ups are necessary and even more protection from radiation is also needed in spring

Melanoma: hereditary one in ten cases, watch out for the sun's rays

More than 750 free dermatological examinations and consultations at the Open Day organised in 90 hospitals by Fondazione Onda with Sidemast and under the patronage of Apiafco to raise awareness of the disease and quality of life for sufferers

Psoriasis high impact in 70% of cases but up to 60% of sufferers drop out of treatment

Thanks to modern diagnostic techniques, the disease can be profiled and thus an 'ad personam' treatment can be set up, with important advantages not only for the individual but also for healthcare

Thanks to modern diagnostic techniques, the disease can be profiled and thus an 'ad personam' treatment can be set up, with important advantages not only for the person but also for health care

Cancer, 'tailor-made' therapy is a reality: customised drugs for over 50,000 patients in Italia

Il carcinoma ovarico è considerato ancora oggi uno dei “big killers” tra le neoplasie ginecologiche, con una sopravvivenza a 5 anni del 43%

Ovarian cancer is still considered one of the 'big killers' among gynaecological malignancies, with a 5-year survival rate of 43%

A national mobilisation unites associations, clinicians and institutions to improve information, prevention and access to innovative treatments against ovarian cancer.

Insieme di Insiemi: the new Italian campaign to inform and support women with ovarian cancer

Signed the two-year intensive protocol between One Health Foundation and FederCUSI, the Italian Federation of University Sport.

Healthy lifestyles, screening and medical counselling take centre stage at university sports centres

Sometimes these conditions can be so serious as to require hospitalisation. A holistic and interdisciplinary view is essential

Cancer: for two out of three patients, drug interactions reduce risks

75% of regular carers of a family member with a disability or chronic illness are women: a pillar of domestic welfare that requires legal protection

In Italia 7 million caregivers: the documentary "Parole in cerca d'autore" arrives

Artificial intelligence is revolutionising medical radiology, but the proportion of women even in top positions is still low

Women and science, only 26% engaged in AI: 'More inclusion needed, gap to be closed'

The Medicines Agency has established the conditions for the reimbursability of the parent of Parp inhibitors indicated in patients with metastatic pancreatic adenocarcinoma who have had no disease progression after at least 16 weeks of a first line of platinum-based chemo

Pancreatic cancer, Aifa approves olaparib With target therapy -47% risk of progression

For the 'fourth leg' of cancer treatment, along with surgery, chemo- and radiotherapy, the prospects for use are widening: triple extension of reimbursability for the immunotherapy molecule pembrolizumab, which becomes usable in 28 different treatment scenarios

Cervical, endometrial and urothelial cancers, how immunotherapy changes treatment strategies

35% of the 50,000 signatures required to submit the popular initiative bill to Parliament have been reached: an important result, but further effort is needed, as Aiom and the Aiom Foundation, which promoted the initiative with the Airc and Veronesi Foundations, warn

35% of the 50,000 signatures required to present the popular initiative bill to Parliament have been reached: an important result, but further effort is needed, as Aiom and the Aiom Foundation, which promoted the initiative with the Airc and Veronesi Foundations, warn

Tumours, 105,000 diagnoses a year due to smoking: 18,000 Italians have already agreed to increase cigarettes by EUR 5

According to Rolando Maria D'Angelillo (Siuro), healthy lifestyles and early diagnosis must be encouraged as much as possible to fight this type of cancer

Urological cancers: 5,500 'hereditary' cases every year in Italy

At the Ministry of Health, the inaugural event of the campaign for Rare Disease Day 2026: institutions and patient associations value treatments that improve the conditions of patients and families, but late diagnoses and territorial inequalities also in neonatal screening remain the key issues

In Italy there are over two million people with a rare disease, around 300 million worldwide

The mister's signature joins those of over 15,000 citizens and dozens of patient associations and scientific societies that have already joined the initiative promoted by the Italian Medical Oncology Association, Airc Foundation, Veronesi Foundation and Aiom Foundation

'I sign to increase the price of cigarettes by €5': Allegri joins campaign

Aifa has given the go-ahead for the reimbursability of CAR-T therapy in patients refractory to first-line chemo-immunotherapy or relapsed within 12 months after completion of first-line chemo-immunotherapy. The treatment is indicated in specific cases

Non-Hodgkin's lymphomas, earlier CAR-T for those who do not respond to treatment in large B-cell forms

Supporting new projects, especially in the maternal-infant area: the Joe Damiani Band's Groove ensemble concert will raise funds at the Borsoni Theatre in Brescia to help increasingly promote the study and application of advanced technologies

Rare diseases: an evening for the Golgi Foundation. Music and solidarity to promote biomedical research

The initiative is promoted by the Italian Medical Oncology Association, the Airc Foundation for Cancer Research, the Umberto Veronesi Foundation and the Aiom Foundation: it aims to collect the at least 5,000 signatures required for a popular initiative bill

Smoking, 27% of cancer cases and 26 bn costs: Italy's first campaign to increase the price of cigarettes by 5 euro

Out of approximately 56,000 new cases a year, almost one in ten affects young people under 40. Thanks to targeted therapies, fertility can increasingly be preserved and the desire for motherhood fulfilled

Breast cancer in under 40s, pregnancy after treatment is possible: here's the latest from science

Precision therapies and more homogeneous scientific data among priorities identified by the Nino Amadore Cancer Institute

Cancer: European Manifesto for Digital Health and Cancer Care is launched

For the Aiom Foundation, the association of oncology physicians, these examinations should soon be included in the new Essential Levels of Care

Breast and ovarian cancer: one in ten is hereditary. Here's why genetic testing is important

President Carrafiello: 'Results comparable to traditional surgery in particular in cancers of the liver, lung, pancreas and kidney'

Interventional radiology: mini-invasiveness and innovation for the fourth pillar of oncology

An estimated 390,000 new diagnoses will be made in 2025, with a downward trend in men, while the mortality rate is below the EU average, thanks in part to the 'protective factor' of public health. South catching up on free tests but hope trips three times higher than in the Centre-North

Aiom 2025 report: cancer mortality down 9% in Italy, but prevention and inequalities remain crucial challenges

The National Association of Breast Operated Women and the more than 18,500 Federfarma member pharmacies jointly promote the national screening campaign

Breast cancer: one in eight women at risk, but only one in two does mammography screening

The number of cases in women under 40 has almost doubled in the last 30 years: incorrect lifestyles such as obesity, alcohol and smoking are to blame, and it is essential to initiate genetic counselling pathways that allow prevention and possible treatment to be planned in a more targeted and effective manner

Breast cancer, here's why mammography should be anticipated throughout Italy from the age of 45

The first study in the world to demonstrate the equal efficacy of surgery and high-dose radiotherapy in this rare bone tumour is Italian. The key role of Pavia's CNAO

To treat chordoma of the sacrum adrotherapy as effective as a scalpel but with fewer effects

According to a survey by the AIOM Foundation, only one in ten patients with endocrine-responsive and HER-2-negative metastatic cancer in Italy would perform the test

Liquid biopsy, how much women with advanced breast cancer need it and why there is room for improvement

The areas involved range from Cardiovascular to Oncology, from Neuroscience to Digital Health, to Data Science and Omics. Bristol Myers Squibb Italy co-funded the PhDs

Precision medicine to change clinical practice: eight innovative doctorates launched

President Fraggetta: accelerate the modernisation of healthcare facilities also to accommodate AI innovations and increase the number of specialists

Pathological anatomy: digital slide in only one in three laboratories, hi-tech breakthrough needed

Green light from Aifa for the reimbursability of a new drug. Compared to hormone treatment alone, in combination it reduces the risk of disease progression or death

Breast cancer, new 'tailor-made' therapy for advanced forms arrives

Aifa approved the extension of the reimbursability of the therapy that acts on ineffective marrow erythropoiesis, i.e. the lack of or insufficient production of red blood cells

Myelodysplasias, green light for therapy that can make six out of ten patients independent of transfusions

In Italy, there are more than 14,000 cases per year and approximately 5,000 deaths. The results of the NO-CUT clinical study change and improve clinical practice

Rectal cancer: 25% of patients can be cured without surgery

The new edition of the campaign against 'vaccine hesitation' arrives in Pisa. Specialists recommend anti-pneumococcal, anti-flu and those against Herpes Zoster, HPV and Covid-19

Patients living with a cancer diagnosis 'must have five vaccinations

More patients are alive: +10% in three years, but the disease remains among the most difficult to treat and only one in five cases is operable. Late diagnosis in 80% of cases

Pancreatic cancer, more diagnoses, fewer deaths. Italy accelerates on prevention

Specialists at conference in Turin. Thanks to technology and innovation, the indications for these treatments are expanding. Interdisciplinary approach important

Shorter hospital stays and faster recoveries: the advantages of interventional radiology

Thanks to the vaccine, the risks of several cancers can be reduced. But we need to improve with coverage, for girls and boys

Papilloma virus, more focus on prevention: how much vaccination is worth for males and females

Initiated an Italy-US bridge on the universal themes of food, sport and health at a time when obesity and nutrition-related disorders are on the rise

Prevention: the principles of the Mediterranean diet conquer New York

The disease causes chest pain, palpitations, fatigue. Early diagnosis and access to the most suitable therapies are essential, on a case-by-case basis

Hypertrophic obstructive cardiomyopathy: new drug helps thickening heart

In Italy, mortality in men under 50 has decreased by 38.6% in 15 years, but patients demand that the Diagnostic-Therapeutic Pathway be included in the Essential Levels of Care to guarantee the same opportunities for all

Stomach cancer, early diagnosis in less than 20% of cases and appropriate treatment pathways needed

Experts indicate what can be found and when. And they offer important pointers on how to behave

Sexual assault and date rape drugs, how to find biological traces of psychoactive substances

The election took place during the scientific society's 27th national congress, which was attended by over 3,000 specialists from all over Italy

Italian oncologists elect their top management: Di Maio as president, relay with Berardi ready

Oncologists call for the inclusion of the test in the Lea for those at risk. And they recall the value of genomic testing for precision oncology in breast cancer

Lung cancer, screening can save lives: who needs it, how it is done and why it is important

Its existence was discovered on 8 November 1895: Nicoletta Gandolfo, president of the Italian Society of Medical and Interventional Radiology, recounts this long journey and the changes taking place

X-rays turn 130 years old: 'From the first films to AI, how radiology has changed'

Regular exercise can reduce the risk of developing cancer by up to 20%. And have better results from treatment. the call: more attention needs to be paid to independent clinical studies

Cancer, physical activity becomes prevention and treatment at no cost

Obstacles in taking care, costs for transport from home to the hospital and extra visits, for drugs and supplements: the picture of financial toxicity taken for Italy by Aiom researchers

Tumours, 1,800 euro a year from patients for treatment and 16% of women leave their jobs

Laboratory medicine professionals and clinicians together to design virtuous pathways and foster the sustainability of the health service

Tumours and diseases of the nervous system: how the laboratory discovers them before they appear

AIOM Foundation stars in a tailor-made training course for specialists on the treatment of gynaecological malignancies

Oncologists and burnout risk: how to deal with the needs of carers of women with cancer

In Florence the Breastision event, a national summit on precision therapies in metastatic breast cancer

Metastic breast cancer: increasingly precise treatment thanks to liquid biopsy

Each person gets what he or she needs. From bone diseases to Breast Units, increasingly important tailor-made responses according to need

Starting with needs, the invisible red thread linking rare bone diseases with breast cancer

The acronym indicates what to assess to suspect a stroke and intervene as soon as possible to limit brain damage and increase the chances of recovery

Against stroke every minute counts: two million neurons are lost in 60 seconds, the 'Fast' method

Thanks to biomarkers, treatments with targeted drugs are being expanded, even in the rarest forms. But it is the overall management of the patient that counts, with attention to the psyche and rehabilitation

Brain gliomas, what they are and how to tackle them with precision oncology

A cycle of six meetings is planned from 4 November: guests include psychotherapist Massimo Recalcati, director Andrée Ruth Shammah, physician Marco Venturino, philosopher Massimo Cacciari and essayist Vittorio Lingiardi.

From art to patient care: the psychology agora open to citizens at the Milan State University

Study shows the value of treatment, not yet authorised in Italy, for patients with metastatic hormone-sensitive malignant prostate cancer

Advanced prostate cancer, paving the way for future therapy with radioligand

From conjugated antibodies, first line in triple-negative breast cancer, to combinations with immunotherapy. From Esmo, clinical trials point the way to science

Tumours, increasingly effective treatments thanks to 'combo' therapies: novelties for breast, stomach and bladder

Latest study results from Esmo, the Congress of the European Society for Medical Oncology

Increasingly precise therapies for breast cancer that reduce mortality and recurrence: the latest news

News in the treatment of the form that does not affect muscle Immunotherapy may improve the results of BCG alone for disease-free survival

Bladder cancer, better control with immunotherapy drug combined with standard treatment

Prevention and screening, together with increasingly effective treatments, are changing the game. But high standards must be maintained

Cancers, fewer people die in Italy than in Europe: drastic drops for lungs and stomach

From target population estimation to economic impact assessments: the sharing of key information by the agency would reduce the use of personnel involved in regional policies by almost 40% on average

Faster and more efficient access to medicines with better dialogue between Aifa and the regions

Medicine that puts the whole person at its centre: thus the Rome Trial represents the first prospective demonstration of the superior efficacy of personalised therapies in the management of patients with advanced solid tumours

Tumours, 'made in Italy' study in Nature Medicine certifies precision oncology

Nutritional deficits worsen prognosis and impact treatment. Here comes 'OncoCook', a web series of recipes

Stomach cancer, 50% of sufferers are malnourished: who is at risk and what to do

Europa Donna Italia's requests to institutions ahead of the fifth National Awareness Day on metastatic breast cancer on 13 October

In Italy 52,000 patients live with metastic breast cancer: 'Now cures for all'

Green light for first-line treatment of patients with metastatic non-small cell lung cancer and EGFR mutation

Lung cancer, reimbursable target drug in combination with chemo or alone

Disparities in access to care are mainly caused by age, place of residence, cultural barriers and socio-economic situation

In Italy 6 million with psychiatric and neurological disorders, but too many departments in treatment

Training and raising awareness among inmates and prison staff on correct lifestyles and adherence to screening: agreement between Aiom, Aiom Foundation, Pascale Institute of Naples and the Campania Penitentiary Administration Board

Cancer, in Campania cancer prevention also arrives in prisons

90 per cent of the clinicians surveyed by Aiom ask for clear rules on patient management and 32 per cent state that they are not sufficiently prepared to assist the cancer patient in the final stages also due to the absence of widespread palliative care

Archivio